177Lu-PSMA for advanced prostate cancer: are we ready to play big?

Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2325-2328. doi: 10.1007/s00259-020-05102-4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • Humans
  • Lutetium
  • Male
  • Prostatic Neoplasms* / radiotherapy
  • Prostatic Neoplasms, Castration-Resistant* / radiotherapy

Substances

  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • Lutetium